Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " November 01, 2010":" December 01, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 01, 2010":" December 01, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects
Conditions: HIV;   HIV Infection
Intervention: Biological: SB-728-T
2 Unknown  Impact of Raltegravir on the Viral Reservoirs
Condition: HIV Infection
Intervention:
3 Completed Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir plus one nucleoside;   Drug: lopinavir /ritonavir plus two nucleosides
4 Completed The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
5 Withdrawn A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium
Condition: HIV Infections
Interventions: Drug: Maraviroc/Dapivirine Gel;   Drug: Dapivirine Vaginal Gel;   Drug: Maraviroc Vaginal Gel;   Drug: Matching Placebo Gel
6 Completed Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Condition: HIV
Intervention:
7 Active, not recruiting Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
Condition: HIV
Intervention: Drug: Raltegravir
8 Completed Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Condition: HIV
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
9 Withdrawn A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir
Condition: HIV
Interventions: Drug: Lopinavir;   Drug: Atazanavir
10 Completed The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
Conditions: HIV Infections;   Depression;   Mild Cognitive Impairment
Interventions: Drug: raltegravir single dose;   Drug: ginkgo biloba multiple dose
11 Terminated Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Condition: HIV
Intervention: Drug: CYT107
12 Completed
Has Results
Addressing Psychosocial Needs and HIV Risk in Indian MSM
Conditions: HIV/STI Risk;   HIV/STI Incidence
Intervention: Behavioral: Behavioral intervention
13 Completed
Has Results
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
Condition: HIV-1 Infection
Interventions: Drug: FTC/RPV/TDF;   Drug: PI;   Drug: RTV;   Drug: NRTIs
14 Completed
Has Results
Vitamin D in HIV-Infected Patients on HAART
Conditions: Vitamin D Deficiency;   HIV
Intervention: Dietary Supplement: Vitamin D
15 Completed Effects of Cash Transfer for the Prevention of HIV in Young South African Women
Condition: HIV
Interventions: Behavioral: monthly cash transfer payments for attending school;   Behavioral: B--No cash transfers
16 Completed Post-Exposure Prophylaxis in Health Care Workers
Condition: Human Immunodeficiency Virus
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
17 Unknown  Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3
Condition: HIV-1 Infection
Intervention: Drug: Maraviroc
18 Completed
Has Results
Will Having Alcohol Treatment Improve Functioning?
Conditions: HIV;   Alcoholism
Interventions: Drug: Naltrexone, 50mg, once per day for 4 months;   Other: Sugar pill, 50mg, once per day for 4 months
19 Completed IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Conditions: IRIS;   HIV
Intervention:
20 Completed Study Targeting Affect Regulation
Conditions: HIV;   AIDS;   Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.